HYPODERMIC SYRINGES-SALE House SponsorsRep. Michelle Mussman, Kelly M. Cassidy, Anne Stava-Murray and Jenn Ladisch Douglass Senate Sponsors(Sen. Don Harmon) 1/7/2025HouseSession Sine Die 415 ILCS 5/3.458720 ILCS 635/1from Ch. 38, par. 22-50720 ILCS 635/2from Ch. 38, par. 22-51720 ILCS 635/5 rep. Amends the Hypodermic Syringes and Needles Act. Provides that any supplier (rather than a pharmacist) may sell any amount of (rather than up to 100) sterile hypodermic syringes or needles to a person who is at least 18 years of age. Deletes a provision that a syringe or needle sold must be stored at a pharmacy and in a manner that limits access to the syringes or needles to pharmacists employed at the pharmacy and any persons designated by the pharmacists. Deletes provision that a syringe or needle sold at a pharmacy may be sold only from the pharmacy department of the pharmacy. Makes other conforming changes to the Act. Amends the Environmental Protection Act to make conforming changes.House Floor Amendment No. 2 Replaces everything after the enacting clause. Reinserts the provisions of the introduced bill with the following changes. Amends the Environmental Protection Act. Defines "applicable facility" to include the principal place of business of any government official who is collecting for transport, storage, treatment, transfer, or disposal hypodermic, intravenous, or other medical needles, or hypodermic or intravenous syringes, by reason of his or her official duties (instead of removing from the definition of "applicable facility" the principal place of business of any government official). Amends the Hypodermic Syringes and Needles Act. Deletes the minimum age of 18 for the purchase of hypodermic syringes and needles. 2/3/2023HouseFiled with the Clerk by Rep. Michelle Mussman 2/7/2023HouseFirst Reading 2/7/2023HouseReferred to Rules Committee 2/15/2023HouseAssigned to Health Care Availability & Accessibility Committee 3/7/2023HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Michelle Mussman 3/7/2023HouseHouse Committee Amendment No. 1 Referred to Rules Committee 3/7/2023HouseDo Pass / Short Debate Health Care Availability & Accessibility Committee; 006-003-000 3/7/2023HouseHouse Committee Amendment No. 1 Tabled 3/8/2023HousePlaced on Calendar 2nd Reading - Short Debate 3/21/2023HouseHouse Floor Amendment No. 2 Filed with Clerk by Rep. Michelle Mussman 3/21/2023HouseHouse Floor Amendment No. 2 Referred to Rules Committee 3/22/2023HouseHouse Floor Amendment No. 2 Rules Refers to Health Care Availability & Accessibility Committee 3/22/2023HouseSecond Reading - Short Debate 3/22/2023HouseHeld on Calendar Order of Second Reading - Short Debate 3/23/2023HouseAdded Co-Sponsor Rep. Kelly M. Cassidy 3/23/2023HouseAdded Co-Sponsor Rep. Anne Stava-Murray 3/23/2023HouseAdded Co-Sponsor Rep. Jenn Ladisch Douglass 3/23/2023HouseHouse Floor Amendment No. 2 Recommends Be Adopted Health Care Availability & Accessibility Committee; 005-003-000 3/24/2023HouseHouse Floor Amendment No. 2 Adopted 3/24/2023HousePlaced on Calendar Order of 3rd Reading - Short Debate 3/24/2023HouseThird Reading - Short Debate - Passed 065-037-000 3/27/2023SenateArrive in Senate 3/27/2023SenatePlaced on Calendar Order of First Reading March 28, 2023 3/29/2023SenateChief Senate Sponsor Sen. Don Harmon 3/29/2023SenateFirst Reading 3/29/2023SenateReferred to Assignments 1/7/2025HouseSession Sine Die